Officials want people to understand just how narrow their window to sign up for flexible gap-filler coverage is.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
The Biden administration is attempting to push through a slew of reforms to the controversial MA program in its final months ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.
Washington — Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...
The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration. By Margot Sanger-Katz Margot Sanger-Katz has been ...